2,245
Views
4
CrossRef citations to date
0
Altmetric
Original Article

Potential prebiotic substrates modulate composition, metabolism, virulence and inflammatory potential of an in vitro multi-species oral biofilm

ORCID Icon, , , , , , , & show all
Article: 1910462 | Received 24 Nov 2020, Accepted 25 Mar 2021, Published online: 20 Apr 2021

References

  • Aas JA, Paster BJ, Stokes LN, et al. Defining the normal bacterial flora of the oral cavity. J Clin Microbiol. 2005;43(5721–5732). DOI:https://doi.org/10.1128/JCM.43.11.5721-5732.2005
  • Burne RA, Zeng L, Ahn SJ, et al. Progress dissecting the oral microbiome in caries and health. Adv Dent Res. 2012;24(2):77–17.
  • Dewhirst FE, Chen T, Izard J, et al. The human oral microbiome. J Bacteriol. 2010;192(19):5002–5017.
  • Human Microbiome PC. Structure, function and diversity of the healthy human microbiome. Nature. 2012;486:207–214.
  • Verma D, Garg PK, Dubey AK. Insights into the human oral microbiome. Arch Microbiol. 2018;200(4):525–540.
  • Zaura E, Keijser BJ, Huse SM, et al. Defining the healthy “core microbiome” of oral microbial communities. BMC Microbiol. 2009;9(1):259.
  • Mira A, Simon-Soro A, Curtis MA. Role of microbial communities in the pathogenesis of periodontal diseases and caries. J Clin Periodontol. 2017;44(Suppl 18):S23–S38.
  • Rosier BT, Marsh PD, Mira A. Resilience of the oral microbiota in health: mechanisms that prevent dysbiosis. J Dent Res. 2018;97(4):371–380.
  • Silva N, Abusleme L, Bravo D, et al. Host response mechanisms in periodontal diseases. J Appl Oral Sci. 2015;23:329–355.
  • Darveau RP. Periodontitis: a polymicrobial disruption of host homeostasis. Nat Rev Microbiol. 2010;8(7):481–490.
  • Hajishengallis G, Lamont RJ. Beyond the red complex and into more complexity: the polymicrobial synergy and dysbiosis (PSD) model of periodontal disease etiology. Mol Oral Microbiol. 2012;27(6):409–419.
  • Hajishengallis G, Liang S, Payne MA, et al. Low-abundance biofilm species orchestrates inflammatory periodontal disease through the commensal microbiota and complement. Cell Host Microbe. 2011;10(5):497–506.
  • Marsh PD. Are dental diseases examples of ecological catastrophes? Microbiology. 2003;149(2):279–294.
  • Socransky SS, Haffajee AD. The bacterial etiology of destructive periodontal disease: current concepts. J Periodontol. 1992;63(4s):322–331.
  • Cieplik F, Jakubovics NS, Buchalla W, et al. Resistance toward chlorhexidine in oral bacteria - is there cause for concern? Front Microbiol. 2019;10:587.
  • Kitagawa H, Izutani N, Kitagawa R, et al. Evolution of resistance to cationic biocides in Streptococcus mutans and Enterococcus faecalis. J Dent. 2016;47:18–22.
  • Kulik EM, Waltimo T, Weiger R, et al. Development of resistance of mutans streptococci and Porphyromonas gingivalis to chlorhexidine digluconate and amine fluoride/stannous fluoride-containing mouthrinses, in vitro. Clin Oral Investig. 2015;19(6):1547–1553.
  • Roberts AP, Mullany P. Oral biofilms: a reservoir of transferable, bacterial, antimicrobial resistance. Expert Rev Anti Infect Ther. 2010;8(12):1441–1450.
  • Verspecht T, Rodriguez Herrero E, Khodaparast L, et al. Development of antiseptic adaptation and cross-adaptation in selected oral pathogens in vitro. Sci Rep. 2019;9(1):8326.
  • Devine DA, Marsh PD. Prospects for the development of probiotics and prebiotics for oral applications. J Oral Microbiol. 2009;1(1). DOI:https://doi.org/10.3402/jom.v1i0.1949
  • Marsh PD. Controlling the oral biofilm with antimicrobials. J Dent. 2010;38(Suppl 1):S11–15.
  • Gruner D, Paris S, Schwendicke F. Probiotics for managing caries and periodontitis: systematic review and meta-analysis. J Dent. 2016;48:16–25.
  • Teughels W, Durukan A, Ozcelik A, et al. Clinical and microbiological effects of Lactobacillus reuteri probiotics in the treatment of chronic periodontitis: a randomized placebo-controlled study. J Clin Periodontol. 2013;40(11):1025–1035.
  • Patel R, DuPont HL. New approaches for bacteriotherapy: prebiotics, new-generation probiotics, and synbiotics. Clin Infect Dis. 2015;60(Suppl suppl_2):S108–121.
  • Slomka V, Hernandez-Sanabria E, Rodriguez Herrero E, et al. Nutritional stimulation of commensal oral bacteria suppresses pathogens: the prebiotic concept. J Clin Periodontol. 2017;44(4):344–352.
  • Slomka V, Rodriguez Herrero E, Boon N, et al. Oral prebiotics and the influence of environmental conditions in vitro. J Periodontol. 2018;89(6):708–717.
  • Gibson GR, Hutkins R, Sanders ME, et al. Expert consensus document: the International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nat Rev Gastroenterol Hepatol. 2017;14(8):491–502.
  • Koopman JE, Hoogenkamp MA, Buijs MJ, et al. Changes in the oral ecosystem induced by the use of 8% arginine toothpaste. Arch Oral Biol. 2017;73:79–87.
  • Koopman JE, Röling WFM, Buijs M, et al. Stability and resilience of oral microcosms toward acidification and Candida outgrowth by arginine supplementation. Microb Ecol. 2015;69(2):422–433.
  • Wolff M, Corby P, Klaczany G, et al. In vivo effects of a new dentifrice containing 1.5% arginine and 1450 ppm fluoride on plaque metabolism. J Clin Dent. 2013;24(Spec no A):A45–54.
  • Alvarez G, Gonzalez M, Isabal S, et al. Method to quantify live and dead cells in multi-species oral biofilm by real-time PCR with propidium monoazide. AMB Express. 2013;3(1):1.
  • Exterkate RA, Crielaard W, Ten Cate JM. Different response to amine fluoride by Streptococcus mutans and polymicrobial biofilms in a novel high-throughput active attachment model. Caries Res. 2010;44(4):372–379.
  • Herrero ER, Slomka V, Boon N, et al. Dysbiosis by neutralizing commensal mediated inhibition of pathobionts. Sci Rep. 2016;6(1):38179.
  • Vandecasteele SJ, Peetermans WE, Merckx R, et al. Use of gDNA as internal standard for gene expression in staphylococci in vitro and in vivo. Biochem Biophys Res Commun. 2002;291(3):528–534.
  • Herrero ER, Fernandes S, Verspecht T, et al. Dysbiotic biofilms deregulate the periodontal inflammatory response. J Dent Res. 2018;97(5):547–555.
  • Sliepen I, Van Damme J, Van Essche M, et al. Microbial interactions influence inflammatory host cell responses. J Dent Res. 2009;88(11):1026–1030.
  • Diaz PI, Hoare A, Hong BY. Subgingival microbiome shifts and community dynamics in periodontal diseases. J Calif Dent Assoc. 2016;44(7):421–435.
  • Griffen AL, Beall CJ, Campbell JH, et al. Distinct and complex bacterial profiles in human periodontitis and health revealed by 16S pyrosequencing. Isme J. 2012;6(6):1176–1185.
  • Wang GP. Defining functional signatures of dysbiosis in periodontitis progression. Genome Med. 2015;7(1). DOI:https://doi.org/10.1186/s13073-015-0165-z
  • Abusleme L, Dupuy AK, Dutzan N, et al. The subgingival microbiome in health and periodontitis and its relationship with community biomass and inflammation. Isme J. 2013;7(5):1016–1025.
  • Marsh PD. Microbial ecology of dental plaque and its significance in health and disease. Adv Dent Res. 1994;8(2):263–271.
  • Socransky SS, Haffajee AD, Cugini MA, et al. Microbial complexes in subgingival plaque. J Clin Periodontol. 1998;25(2):134–144.
  • Conrads G, de Soet JJ, Song L, et al. Comparing the cariogenic spe Streptococcus sobrin S. mutans on whole genome level. J Oral Microbiol. 2014;6(1):26189.
  • Loesche WJ. Role of Streptococcus mutans in human dental decay. Microbiol Rev. 1986;50(4):353–380.
  • Marsh PD, Featherstone A, McKee AS, et al. A microbiological study of early caries of approximal surfaces in schoolchildren. J Dent Res. 1989;68(7):1151–1154.
  • Hamada S, Slade HD. Biology, immunology, and cariogenicity of Streptococcus mutans. Microbiol Rev. 1980;44(2):331–384.
  • Moye ZD, Burne RA, Zeng L. Uptake and Metabolism of N-Acetylglucosamine and Glucosamine by Streptococcus mutans. Appl Environ Microbiol. 2014;80(16):5053–5067.
  • Beighton D, Russell RR, Whiley RA. A simple biochemical scheme for the differentiation of Streptococcus mutans and Streptococcus sobrinus. Caries Res. 1991;25(3):174–178.
  • Kral TA, Daneo-Moore L. Biochemical differentiation of certain oral streptococci. J Dent Res. 1981;60(9):1713–1718.
  • Homer KA, Patel R, Beighton D. Effects of N-acetylglucosamine on carbohydrate fermentation by Streptococcus mutans NCTC 10449 and Streptococcus sobrinus SL-1. Infect Immun. 1993;61(1):295–302.
  • He J, Hwang G, Liu Y, et al. l-Arginine Modifies the Exopolysaccharide Matrix and Thwarts Streptococcus mutans Outgrowth within Mixed-Species Oral Biofilms. J Bacteriol. 2016;198(19):2651–2661.
  • Zheng X, He J, Wang L, et al. Ecological Effect of Arginine on Oral Microbiota. Sci Rep. 2017;7(1):7206.
  • Palframan RJ, Gibson GR, Rastall RA. Effect of pH and dose on the growth of gut bacteria on prebiotic carbohydrates in vitro. Anaerobe. 2002;8(5):287–292.
  • Davis LM, Martinez I, Walter J, et al. A dose dependent impact of prebiotic galactooligosaccharides on the intestinal microbiota of healthy adults. Int J Food Microbiol. 2010;144(2):285–292.
  • Fernandez YMM, Exterkate RAM, Buijs MJ, et al. Effect of mouthwashes on the composition and metabolic activity of oral biofilms grown in vitro. Clin Oral Investig. 2017;21(4):1221–1230.
  • Periasamy S, Kolenbrander PE. Central role of the early colonizer Veillonella sp. in establishing multispecies biofilm communities with initial, middle, and late colonizers of enamel. J Bacteriol. 2010;192(12):2965–2972.
  • Keller L, Surette MG. Communication in bacteria: an ecological and evolutionary perspective. Nat Rev Microbiol. 2006;4(4):249–258.
  • Bradshaw DJ, Homer KA, Marsh PD, et al. Metabolic cooperation in oral microbial communities during growth on mucin. Microbiology. 1994;140(12):3407–3412.
  • Levy R, Borenstein E. Metabolic modeling of species interaction in the human microbiome elucidates community-level assembly rules. Proc Natl Acad Sci U S A. 2013;110(31):12804–12809.
  • Takahashi N. Microbial ecosystem in the oral cavity: metabolic diversity in an ecological niche and its relationship with oral diseases. Int Congress Series. 2005;1284:103–112.
  • Nyvad B, Crielaard W, Mira A, et al. Dental caries from a molecular microbiological perspective. Caries Res. 2013;47(2):89–102.
  • Takahashi N, Washio J. Metabolomic Effects of Xylitol and Fluoride on Plaque Biofilm in Vivo. J Dent Res. 2011;90(12):1463–1468.
  • Takahashi N, Washio J, Mayanagi G. Metabolomics of supragingival plaque and oral bacteria. J Dent Res. 2010;89(12):1383–1388.
  • Takahashi N. Oral Microbiome Metabolism: from “Who Are They?” to “What Are They Doing?”. J Dent Res. 2015;94(12):1628–1637.
  • Brown SA, Whiteley M. A novel exclusion mechanism for carbon resource partitioning in Aggregatibacter actinomycetemcomitans. J Bacteriol. 2007;189(17):6407–6414.
  • Zeng L, Das S, Burne RA. Utilization of lactose and galactose by Streptococcus mutans: transport, toxicity, and carbon catabolite repression. J Bacteriol. 2010;192(9):2434–2444.
  • Chen YY, Betzenhauser MJ, Snyder JA, et al. Pathways for lactose/galactose catabolism by Streptococcus salivarius. FEMS Microbiol Lett. 2002;209(1):75–79.
  • Elbein AD. The metabolism of alpha,alpha-trehalose. Adv Carbohydr Chem Biochem. 1974;30:227–256.
  • Iturriaga G, Suarez R, Nova-Franco B. Trehalose metabolism: from osmoprotection to signaling. Int J Mol Sci. 2009;10(9):3793–3810.
  • Baker JL, Lindsay EL, Faustoferri RC, et al. Characterization of the Trehalose Utilization Operon in Streptococcus mutans Reveals that the TreR Transcriptional Regulator Is Involved in Stress Response Pathways and Toxin Production. J Bacteriol. 2018;200(12). DOI:https://doi.org/10.1128/JB.00057-18
  • Nagasawa R, Sato T, Senpuku H. Raffinose Induces Biofilm Formation by Streptococcus mutans in Low Concentrations of Sucrose by Increasing Production of Extracellular DNA and Fructan. Appl Environ Microbiol. 2017;83(15). DOI:https://doi.org/10.1128/AEM.00869-17
  • Hachem MA, Fredslund F, Andersen JM, et al. Raffinose family oligosaccharide utilisation by probiotic bacteria: insight into substrate recognition, molecular architecture and diversity of GH36 α-galactosidases. Biocatalysis and Biotransformation. 2012;30(3):316–325.
  • Chow J, Tang H, Mazmanian SK. Pathobionts of the gastrointestinal microbiota and inflammatory disease. Curr Opin Immunol. 2011;23(4):473–480.
  • Cugini C, Klepac-Ceraj V, Rackaityte E, et al. Porphyromonas gingivalis : keeping the pathos out of the biont. J Oral Microbiol. 2013;5(1). DOI:https://doi.org/10.3402/jom.v5i0.19804
  • Arimatsu K, Yamada H, Miyazawa H, et al. Oral pathobiont induces systemic inflammation and metabolic changes associated with alteration of gut microbiota. Sci Rep. 2014;4(1):4828.
  • Norskov-Lauritsen N, Claesson R, Birkeholm Jensen A, et al. Aggregatibacter Actinomycetemcomitans: clinical Significance of a Pathobiont Subjected to Ample Changes in Classification and Nomenclature. Pathogens. 2019;8(4). DOI:https://doi.org/10.3390/pathogens8040243
  • Han YW. Fusobacterium nucleatum: a commensal-turned pathogen. Curr Opin Microbiol. 2015;23:141–147.
  • Darveau RP, Hajishengallis G, Curtis MA. Porphyromonas gingivalis as a Potential Community Activist for Disease. J Dent Res. 2012;91(9):816–820.
  • Kaplan JB, Velliyagounder K, Ragunath C, et al. Genes involved in the synthesis and degradation of matrix polysaccharide in Actinobacillus actinomycetemcomitans and Actinobacillus pleuropneumoniae biofilms. J Bacteriol. 2004;186(24):8213–8220.
  • Umeda JE, Longo PL, Simionato MR, et al. Differential transcription of virulence genes in Aggregatibacter actinomycetemcomitans serotypes. J Oral Microbiol. 2013;5(1). DOI:https://doi.org/10.3402/jom.v5i0.21473
  • Bosse JT, Sinha S, Li MS, et al. Regulation of PGA operon expression and biofilm formation in Actinobacillus pleuropneumoniae by sigmaE and H-NS. J Bacteriol. 2010;192(9):2414–2423.
  • Naseem S, Konopka JB. N-acetylglucosamine Regulates Virulence Properties in Microbial Pathogens. PLoS Pathog. 2015;11(7):e1004947.
  • Konopka JB. N-acetylglucosamine (GlcNAc) functions in cell signaling. Scientifica (Cairo);2012. DOI:https://doi.org/10.6064/2012/489208 2012
  • Duran-Pinedo AE, Yost S, Small F-LJ. RNA Transcriptome of the Oral Microbiome during Periodontitis Progression. Appl Environ Microbiol. 2015;81(19):6688–6699.
  • Frias-Lopez J, Duran-Pinedo A. Effect of periodontal pathogens on the metatranscriptome of a healthy multispecies biofilm model. J Bacteriol. 2012;194(8):2082–2095.
  • Knudsen GM, Holch A, Gram L. Subinhibitory concentrations of antibiotics affect stress and virulence gene expression in Listeria monocytogenes and cause enhanced stress sensitivity but do not affect Caco-2 cell invasion. J Appl Microbiol. 2012;113(5):1273–1286.
  • Liu Q, Zheng Z, Kim W, et al. Influence of subinhibitory concentrations of NH125 on biofilm formation & virulence factors of Staphylococcus aureus. Future Med Chem. 2018;10(11):1319–1331.
  • Kastbjerg VG, Larsen MH, Gram L, et al. Influence of sublethal concentrations of common disinfectants on expression of virulence genes in Listeria monocytogenes. Appl Environ Microbiol. 2010;76(1):303–309.
  • Szafranski SP, Deng ZL, Tomasch J, et al. Functional biomarkers for chronic periodontitis and insights into the roles of Prevotella nigrescens and Fusobacterium nucleatum; a metatranscriptome analysis. NPJ Biofilms Microbiomes. 2015;1(1):15017.
  • Duran-Pinedo AE, Chen T, Teles R, et al. Community-wide transcriptome of the oral microbiome in subjects with and without periodontitis. Isme J. 2014;8(8):1659–1672.
  • Yost S, Duran-Pinedo AE, Teles R, et al. Functional signatures of oral dysbiosis during periodontitis progression revealed by microbial metatranscriptome analysis. Genome Med. 2015;7(1):27.
  • Lamont RJ, Hajishengallis G. Polymicrobial synergy and dysbiosis in inflammatory disease. Trends Mol Med. 2015;21(3):172–183.
  • Yost S, Duran-Pinedo AE, Krishnan K, et al. Potassium is a key signal in host-microbiome dysbiosis in periodontitis. PLoS Pathog. 2017;13(6):e1006457.
  • Lamont RJ, Koo H, Hajishengallis G. The oral microbiota: dynamic communities and host interactions. Nature Rev Microbiol. 2018;16(12):745–759.
  • Lamont RJ, Koo H, Hajishengallis G. The oral microbiota: dynamic communities and host interactions. Nat Rev Microbiol. 2018;16(12):745–759.
  • Mysak J, Podzimek S, Sommerova P, et al. Porphyromonas gingivalis: major periodontopathic pathogen overview. J Immunol Res. 2014;2014:476068.
  • Larsen JM. The immune response to Prevotella bacteria in chronic inflammatory disease. Immunology. 2017;151(4):363–374.
  • Pan W, Wang Q, Chen Q. The cytokine network involved in the host immune response to periodontitis. Int J Oral Sci. 2019;11:30.
  • Stathopoulou PG, Benakanakere MR, Galicia JC, et al. Epithelial cell pro-inflammatory cytokine response differs across dental plaque bacterial species. J Clin Periodontol. 2010;37(1):24–29.
  • Groeger S, Meyle J. Oral Mucosal Epithelial Cells. Front Immunol. 2019;10:208.
  • Fukui A, Ohta K, Nishi H, et al. Interleukin-8 and CXCL10 expression in oral keratinocytes and fibroblasts via Toll-like receptors. Microbiol Immunol. 2013;57(3):198–206.
  • Goutoudi P, Diza E, Arvanitidou M. Effect of periodontal therapy on crevicular fluid interleukin-6 and interleukin-8 levels in chronic periodontitis. Int J Dent. 2012;2012:362905.
  • Schueller K, Riva A, Pfeiffer S, et al. Members of the Oral Microbiota Are Associated with IL-8 Release by Gingival Epithelial Cells in Healthy Individuals. Front Microbiol. 2017;8:416.
  • Pollanen MT, Overman DO, Salonen JI. Bacterial metabolites sodium butyrate and propionate inhibit epithelial cell growth in vitro. J Periodontal Res. 1997;32(3):326–334.
  • Tsuda H, Ochiai K, Suzuki N, et al. Butyrate, a bacterial metabolite, induces apoptosis and autophagic cell death in gingival epithelial cells. J Periodontal Res. 2010;45(5):626–634.
  • Qiqiang L, Huanxin M, Xuejun G. Longitudinal study of volatile fatty acids in the gingival crevicular fluid of patients with periodontitis before and after nonsurgical therapy. J Periodontal Res. 2012;47(6):740–749.
  • Periasamy S, Kolenbrander PE. Mutualistic biofilm communities develop with Porphyromonas gingivalis and initial, early, and late colonizers of enamel. J Bacteriol. 2009;191(22):6804–6811.
  • Marsh PD. Contemporary perspective on plaque control. Br Dent J. 2012;212(12):601–606.